Catherine T. Doherty sold $5.4M of Quest Diagnostics Incorporated (DGX)

Executed Nov 27 2024, disclosed Dec 2 2024, 5 days later.

Value, as filed

$5.4M

33,103 sh across 2 lots

Executed

Nov 27 2024

the trade date, as filed

Disclosed

Dec 2 2024

5 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Catherine T. Doherty Executive Vice President profile →

Catherine T. Doherty (Executive Vice President) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Quest Diagnostics Incorporated (DGX). The largest single filing was $5.5M of DGX (22,105 sh across 7 lots, as filed), executed Nov 3.

The name

DGX

Quest Diagnostics Incorporated DGX · Healthcare · 49 filings in 24 months ticker →

Healthcare · Quest Diagnostics Incorporated provides diagnostic testing and services in the United States

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Catherine T. Doherty in DGX

DGXSALE Quest Diagnostics Incorporated $5.5M
22,105 sh across 7 lots
Exec Nov 3
Filed Nov 5 · 7:05 PM ET DGXSALE Quest Diagnostics Incorporated $1.1M
5,558 sh × $206.21
Exec Mar 5
Filed Mar 6 · 5:30 PM ET DGXSALE Quest Diagnostics Incorporated $131K
632 sh × $207.73
Exec Mar 3
Filed Mar 4 · 5:30 PM ET DGXSALE Quest Diagnostics Incorporated $294K
1,433 sh × $204.83
Exec Feb 19
Filed Feb 20 · 5:30 PM ET DGXSALE Quest Diagnostics Incorporated $5.3M
25,814 sh across 4 lots
Exec Feb 13
Filed Feb 17 · 5:30 PM ET DGXSALE Quest Diagnostics Incorporated $935K
5,370 sh × $174.13
Exec Mar 5 2025
Filed Mar 7 2025 · 5:30 PM ET DGXSALE Quest Diagnostics Incorporated $126K
716 sh × $175.79
Exec Mar 4 2025
Filed Mar 5 2025 · 5:30 PM ET DGXSALE Quest Diagnostics Incorporated $142K
824 sh × $172.61
Exec Feb 27 2025
Filed Feb 28 2025 · 5:30 PM ET